Paper36765788
Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures.
Zou X and 12 others. Cancers (Basel), 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures. Papers, record 36765788. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765788
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32191346 | 12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer. | Int J Cancer | 2020 | https://conductscience.org/library/papers/32191346 | PubMed |
| 2 | 35092511 | A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy. | Med Oncol | 2022 | https://conductscience.org/library/papers/35092511 | PubMed |
| 3 | 30701026 | Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma. | Oncotarget | 2018 | https://conductscience.org/library/papers/30701026 | PubMed |
| 4 | 10953052 | Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. | Mol Pharmacol | 2000 | https://conductscience.org/library/papers/10953052 | PubMed |
| 5 | 33409403 | A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC). | Transl Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33409403 | PubMed |
| 6 | 30655846 | Efficacy and safety of TE/TEC/intensive paclitaxel neoadjuvant chemotherapy for the treatment of breast cancer. | Oncol Lett | 2019 | https://conductscience.org/library/papers/30655846 | PubMed |
| 7 | 34098945 | Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34098945 | PubMed |
| 8 | 33167864 | Estrogen receptors α, β and GPER in the CNS and trigeminal system - molecular and functional aspects. | J Headache Pain | 2020 | https://conductscience.org/library/papers/33167864 | PubMed |
| 9 | 28476123 | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer. | Mol Cancer | 2017 | https://conductscience.org/library/papers/28476123 | PubMed |
| 10 | 34990248 | Tertiary lymphoid structures in cancer. | Science | 2022 | https://conductscience.org/library/papers/34990248 | PubMed |
| 11 | 31788039 | The roles of estrogen and estrogen receptors in gastrointestinal disease. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31788039 | PubMed |
| 12 | 31151315 | Sex Hormone Receptor Signals in Human Malignancies. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31151315 | PubMed |
| 13 | 30834048 | Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. | World J Oncol | 2019 | https://conductscience.org/library/papers/30834048 | PubMed |
| 14 | 31092904 | Tertiary lymphoid structures in the era of cancer immunotherapy. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/31092904 | PubMed |
| 15 | 29666308 | Estrogen receptor α contributes to T cell-mediated autoimmune inflammation by promoting T cell activation and proliferation. | Sci Signal | 2018 | https://conductscience.org/library/papers/29666308 | PubMed |
| 16 | 21726119 | Estrogen promotes B cell activation in vitro through down-regulating CD80 molecule expression. | Gynecol Endocrinol | 2011 | https://conductscience.org/library/papers/21726119 | PubMed |
| 17 | 17249692 | Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics. | Biochemistry | 2007 | https://conductscience.org/library/papers/17249692 | PubMed |
| 18 | 30916958 | Heterogeneous CPU+GPU-Enabled Simulations for DFTB Molecular Dynamics of Large Chemical and Biological Systems. | J Chem Theory Comput | 2019 | https://conductscience.org/library/papers/30916958 | PubMed |
| 19 | 33796412 | Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/33796412 | PubMed |
| 20 | 29463044 | The Role of the Estrogen Pathway in the Tumor Microenvironment. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29463044 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958510 | Association between a combined lifestyle exposure index and age at pancreatic cancer diagnosis: a hospital-based retrospective study. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42958510 | PubMed |
| 42511782 | Integrating Network Toxicology with Molecular Dynamics Simulations to Reveal Key Targets and Binding Mechanisms of Bisphenol A in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511782 | PubMed |
| 42329496 | Tertiary Lymphoid Structure: A Potential Therapeutic Target Affecting Immune Response in Autoimmune Diseases. | Clin Rev Allergy Immunol | 2026 | https://conductscience.org/library/papers/42329496 | PubMed |
| 41154404 | Tumor Characteristics and Clinical Features of the Patient as Prognostic Factors in PDAC. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41154404 | PubMed |
| 41112246 | The dual nature of immunotherapy in female reproductive disorders: immune homeostasis and clinical challenges. | Front Immunol | 2025 | https://conductscience.org/library/papers/41112246 | PubMed |
| 41095698 | A Pilot Study of Exploring miRNA-Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41095698 | PubMed |
| 40303343 | Sex bias in tumor immunity: insights from immune cells. | Theranostics | 2025 | https://conductscience.org/library/papers/40303343 | PubMed |
| 38694662 | Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters. | Cureus | 2024 | https://conductscience.org/library/papers/38694662 | PubMed |
| 37627225 | Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37627225 | PubMed |
| 37529035 | Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37529035 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765788
GET https://conductscience.org/api/papers/v1/36765788/references?page=2